###begin article-title 0
###xml 122 125 <span type="species:ncbi:9685">Cat</span>
Gene-Environment Interaction in the Onset of Eczema in Infancy: Filaggrin Loss-of-Function Mutations Enhanced by Neonatal Cat Exposure 
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 155 159 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG-</italic>
###xml 302 305 302 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
Loss-of-function variants in the gene encoding filaggrin (FLG) are major determinants of eczema. We hypothesized that weakening of the physical barrier in FLG-deficient individuals may potentiate the effect of environmental exposures. Therefore, we investigated whether there is an interaction between FLG loss-of-function mutations with environmental exposures (pets and dust mites) in relation to the development of eczema.
###end p 2
###begin title 3
Methods and Findings
###end title 3
###begin p 4
###xml 296 297 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 306 309 306 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 443 444 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 542 545 542 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 585 586 585 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 665 666 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 695 698 695 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 724 725 724 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 823 826 823 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 878 879 878 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 978 981 978 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 1020 1021 1020 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1124 1125 1124 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 498 501 <span type="species:ncbi:9685">cat</span>
###xml 528 536 <span type="species:ncbi:9606">children</span>
###xml 598 601 <span type="species:ncbi:9615">dog</span>
###xml 951 954 <span type="species:ncbi:9685">cat</span>
###xml 1082 1085 <span type="species:ncbi:9615">dog</span>
We used data obtained in early life in a high-risk birth cohort in Denmark and replicated the findings in an unselected birth cohort in the United Kingdom. Primary outcome was age of onset of eczema; environmental exposures included pet ownership and mite and pet allergen levels. In Copenhagen (n = 379), FLG mutation increased the risk of eczema during the first year of life (hazard ratio [HR] 2.26, 95% confidence interval [CI] 1.27-4.00, p = 0.005), with a further increase in risk related to cat exposure at birth amongst children with FLG mutation (HR 11.11, 95% CI 3.79-32.60, p < 0.0001); dog exposure was moderately protective (HR 0.49, 95% CI 0.24-1.01, p = 0.05), but not related to FLG genotype. In Manchester (n = 503) an independent and significant association of the development of eczema by age 12 mo with FLG genotype was confirmed (HR 1.95, 95% CI 1.13-3.36, p = 0.02). In addition, the risk increased because of the interaction of cat ownership at birth and FLG genotype (HR 3.82, 95% CI 1.35-10.81, p = 0.01), with no significant effect of the interaction with dog ownership (HR 0.59, 95% CI 0.16-2.20, p = 0.43). Mite-allergen had no effects in either cohort. The observed effects were independent of sensitisation.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 350 353 350 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 412 416 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG-</italic>
###xml 115 118 <span type="species:ncbi:9685">cat</span>
###xml 234 237 <span type="species:ncbi:9685">cat</span>
###xml 246 249 <span type="species:ncbi:9615">dog</span>
###xml 336 344 <span type="species:ncbi:9606">children</span>
###xml 456 460 <span type="species:ncbi:9685">cats</span>
###xml 469 473 <span type="species:ncbi:9615">dogs</span>
We have demonstrated a significant interaction between FLG loss-of-function main mutations (501x and 2282del4) and cat ownership at birth on the development of early-life eczema in two independent birth cohorts. Our data suggest that cat but not dog ownership substantially increases the risk of eczema within the first year of life in children with FLG loss-of-function variants, but not amongst those without. FLG-deficient individuals may need to avoid cats but not dogs in early life.
###end p 6
###begin p 7
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 30 38 <span type="species:ncbi:9606">children</span>
###xml 45 53 <span type="species:ncbi:28154">Bisgaard</span>
###xml 152 156 <span type="species:ncbi:9685">cats</span>
###xml 166 170 <span type="species:ncbi:9615">dogs</span>
In two independent cohorts of children, Hans Bisgaard and colleagues show an association between mutations in the filaggrin gene (FLG) and ownership of cats, but not dogs, with development of eczema.
###end p 7
###begin title 8
Editors' Summary
###end title 8
###begin title 9
Background.
###end title 9
###begin p 10
###xml 338 345 <span type="species:ncbi:9606">infants</span>
Eczema is a skin condition characterized by dry, red, and itchy patches on the skin. Eczema is associated with asthma and allergy, though allergy rarely plays a role in development or severity of eczema. Eczema usually begins during infancy, typically on the face, scalp, neck, extensor sides of the forearms, and legs. Up to one in five infants develops eczema, but in more than half of them, the condition improves or disappears completely before they are 15 years old. If eczema persists into adulthood, it usually affects the face and the skin inside the knees and elbows. There is no cure for eczema but it can be controlled by avoiding anything that makes its symptoms worse. These triggers include irritants such as wool, strong soaps, perfumes, and dry environments. A good skin-care routine and frequent moisturizing can also help to keep eczema under control, but in many cases, corticosteroid creams and ointments may be necessary to reduce inflammation.
###end p 10
###begin title 11
Why Was This Study Done?
###end title 11
###begin p 12
###xml 234 237 234 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 250 256 <span type="species:ncbi:9606">people</span>
###xml 268 274 <span type="species:ncbi:9606">People</span>
Eczema tends to run in families. This suggests that eczema is caused by genetic factors as well as by environmental factors. Recently, researchers discovered that two common "loss-of-function" variants in the gene encoding filaggrin (FLG) predispose people to eczema. People who inherit one or two defective genes make no filaggrin, a protein that normally forms a physical barrier in the skin that protects the body from potentially harmful substances in the environment. Might the weakening of this barrier in filaggrin-deficient individuals affect their responses to environmental substances to which the skin is exposed? In this study, the researchers test this potential explanation for how genetic and environmental factors (in particular, exposure to pets) might interact to determine an individual's chances of developing eczema.
###end p 12
###begin title 13
What Did the Researchers Do and Find?
###end title 13
###begin p 14
###xml 336 339 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 438 441 438 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 455 458 455 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 748 751 748 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 851 854 851 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 887 890 887 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 976 979 976 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 76 83 <span type="species:ncbi:9606">infants</span>
###xml 148 155 <span type="species:ncbi:9606">infants</span>
###xml 222 229 <span type="species:ncbi:9606">infants</span>
###xml 238 243 <span type="species:ncbi:9606">women</span>
###xml 354 359 <span type="species:ncbi:9606">child</span>
###xml 532 535 <span type="species:ncbi:9615">dog</span>
###xml 541 544 <span type="species:ncbi:9685">cat</span>
###xml 586 591 <span type="species:ncbi:9606">child</span>
###xml 734 742 <span type="species:ncbi:9606">children</span>
###xml 834 842 <span type="species:ncbi:9606">children</span>
###xml 870 878 <span type="species:ncbi:9606">children</span>
###xml 902 905 <span type="species:ncbi:9685">cat</span>
###xml 962 970 <span type="species:ncbi:9606">children</span>
###xml 991 994 <span type="species:ncbi:9685">cat</span>
###xml 1023 1026 <span type="species:ncbi:9615">dog</span>
To test their hypothesis, the researchers studied two independent groups of infants during their first year of life-a high-risk group consisting of infants born in Copenhagen, Denmark to mothers with asthma and a group of infants born to women from the general population in Manchester, United Kingdom. The researchers determined which FLG variants each child had inherited and classified those with either one or two defective copies of FLG as having an FLG mutation. They determined pet exposure in early life by asking whether a dog or a cat was living in the parental home when the child was born ("pet ownership") and then analyzed how these genetic and environmental factors affected the age of onset of eczema. In both groups, children with FLG mutations were twice as likely to develop eczema during the first year of life as children without FLG mutations. For children without FLG mutations, cat ownership at birth had no effect on eczema risk but for children with FLG mutations, cat ownership at birth (but not dog ownership) further increased the risk of developing eczema.
###end p 14
###begin title 15
What Do These Findings Mean?
###end title 15
###begin p 16
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 448 451 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 684 687 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 43 46 <span type="species:ncbi:9685">cat</span>
###xml 105 110 <span type="species:ncbi:9606">child</span>
###xml 330 335 <span type="species:ncbi:9606">child</span>
###xml 380 383 <span type="species:ncbi:9685">cat</span>
###xml 417 425 <span type="species:ncbi:9606">children</span>
###xml 482 486 <span type="species:ncbi:9685">cats</span>
###xml 608 612 <span type="species:ncbi:9685">cats</span>
###xml 698 706 <span type="species:ncbi:9606">children</span>
###xml 718 721 <span type="species:ncbi:9685">cat</span>
###xml 763 766 <span type="species:ncbi:9685">cat</span>
###xml 934 938 <span type="species:ncbi:9685">cats</span>
###xml 948 952 <span type="species:ncbi:9615">dogs</span>
These findings show that FLG mutations and cat ownership at birth interact to determine the chances of a child developing eczema during the first year of life. They provide support, therefore, for the researchers' suggestion that the weakening of the skin's protective barrier that is caused by filaggrin deficiency increases the child's susceptibility to factors associated with cat exposure. Only a small number of children in this study carried FLG mutations and were exposed to cats from birth, so these findings need confirming in independent studies. In addition, it is still not clear how exposure to cats drives the development of eczema. Allergy was not the mechanism as the FLG-deficient children exposed to cat and who developed eczema did not develop cat-specific immunoglobin E antibodies. Nevertheless, these findings suggest that, to reduce their risk of developing eczema, filaggrin-deficient individuals should avoid cats (but not dogs) during the first few months of life.
###end p 16
###begin title 17
Additional Information.
###end title 17
###begin p 18
Please access these Web sites via the online version of this summary at .
###end p 18
###begin p 19
The MedlinePlus Encyclopedia has a page on  (in English and Spanish); links to further information are provided by 
###end p 19
###begin p 20
 is a comprehensive online information resource about eczema provided by the American Academy of Dermatologists
###end p 20
###begin p 21
The US National Institute of Arthritis and Musculoskeletal and Skin Diseases provides information on 
###end p 21
###begin p 22
###xml 83 91 <span type="species:ncbi:9606">patients</span>
The UK National Health Service Direct health encyclopedia provides information for patients on  (in several languages)
###end p 22
###begin p 23
###xml 55 63 <span type="species:ncbi:9606">children</span>
The  and  Web sites provide more information about the children involved in this research
###end p 23
###begin title 24
Introduction
###end title 24
###begin p 25
###xml 154 157 154 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b001">1</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b002">2</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b004">4</xref>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b002">2</xref>
We recently discovered in the Copenhagen Prospective Study on Asthma in Childhood (COPSAC) that loss-of-function variants in the gene encoding filaggrin (FLG) are major determinants of eczema [1]. This finding has since been replicated in other populations [2-4], and the population attributable risk for eczema estimated at 11% [2].
###end p 25
###begin p 26
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 693 694 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b005">5</xref>
FLG is situated in the Epidermal Differentiation Complex, a dense cluster of genes on Chromosome 1q21. It codes for the 500-kDa protein profilaggrin, which is the main protein component of the keratohyalin granules within the outermost living cell layers of the epidermis. During terminal differentiation of keratinocytes, profilaggrin is dephosphorylated into filaggrin peptides (37-kDa proteins), which form highly compacted, chemically cross-linked layers that provide a physical barrier that reduces water loss and protects the body from potentially harmful environmental exposures. Non-sense mutation R501X and frame-shift mutation 2282del4 lead to complete loss of filaggrin expression [5], which causes excessively dry skin and impaired skin barrier function.
###end p 26
###begin p 27
###xml 222 225 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 344 347 344 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 473 476 473 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
We hypothesized that weakening of skin barrier function in filaggrin-deficient individuals may modulate the effect of environmental exposures, thus modifying the expression of eczema. Since most eczema in individuals with FLG mutations occurs within the first year of life, the important environment exposures that may affect the penetrance of FLG mutations are likely to occur in the first months of life. We therefore investigated whether there is an interaction between FLG loss-of-function mutations with early-life environmental exposures (pets and dust mites) in relation to the development of eczema. We used data obtained in a high-risk birth cohort in Denmark, and in an unselected birth cohort in the UK.
###end p 27
###begin title 28
Methods
###end title 28
###begin title 29
COPSAC
###end title 29
###begin p 30
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b006">6</xref>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b008">8</xref>
COPSAC enrolled 411 high-risk neonates (mother with verified asthma) at age 1 mo; the recruitment was previously described in detail [6-8]. The study was approved by the Ethics Committee for Copenhagen (KF 01-289/96) and The Danish Data Protection Agency (2008-41-1754). Before enrolment, informed consent was obtained from parents. Data were collected on-line and locked after external monitoring. An audit trail was run routinely.
###end p 30
###begin title 31
Primary outcome.
###end title 31
###begin p 32
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b009">9</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b010">10</xref>
###xml 48 60 <span type="species:ncbi:9606">participants</span>
Eczema was diagnosed on clinical examination in participants who were assessed at the COPSAC Clinical Research Unit at age 1 mo, and at 6-mo intervals thereafter; additional visits were arranged immediately upon the onset of any skin or respiratory symptoms. Skin examinations, diagnoses, and treatment of eczema were carried out by trained study physicians. Skin lesions were described on-line according to predefined morphology and localization; eczema was defined based on the Hanifin-Rajka criteria as previously detailed [9,10].
###end p 32
###begin title 33
Secondary outcome.
###end title 33
###begin p 34
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b011">11</xref>
Allergic sensitisation was defined as specific IgE > 0.35 kU/l to a range of common inhalant and food allergens at age 6 and 18 mo (ImmunoCAP, Phadia) [11].
###end p 34
###begin title 35
Environmental exposures.
###end title 35
###begin p 36
###xml 92 95 <span type="species:ncbi:9685">cat</span>
###xml 99 102 <span type="species:ncbi:9615">dog</span>
Pet exposure in early life was determined at the interview at the 1-mo visit and defined as cat or dog living in the house at birth.
###end p 36
###begin p 37
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b012">12</xref>
###xml 70 75 <span type="species:ncbi:9606">child</span>
###xml 205 208 <span type="species:ncbi:9685">cat</span>
###xml 214 217 <span type="species:ncbi:9615">dog</span>
Allergen exposure was measured in the dust samples collected from the child's bed at age 1 y. Parents vacuumed the bedding (the pillow and mattress) for 5 min with a dust trap attached (ALK-Abello). Mite, cat, and dog allergen concentration was measured using the Sandwich ELISA [12]. Allergen exposure was dichotomized as high and low levels (above and below the 75% quartile).
###end p 37
###begin p 38
###xml 129 151 129 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus.</italic>
###xml 9 15 <span type="species:ncbi:3635">cotton</span>
###xml 129 150 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Charcoal cotton swabs were taken from the perineum of the newborn and transported in Stuart transport media for routine test for Staphylococcus aureus.
###end p 38
###begin title 39
Manchester Asthma and Allergy Study
###end title 39
###begin p 40
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b013">13</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b014">14</xref>
###xml 172 184 <span type="species:ncbi:9606">Participants</span>
Manchester Asthma and Allergy Study (MAAS) is an unselected population-based birth cohort described in detail elsewhere [13,14]. The study is registered as ISRCTN72673620. Participants were recruited prenatally, and followed prospectively, attending the first review clinic at ages 1, 3, and 5 y (+/- 4 wk). The study was approved by the Local Research Ethics Committee (SOU/00/258; SOU/00/259). Written informed consent was obtained from all parents.
###end p 40
###begin title 41
Primary outcome.
###end title 41
###begin p 42
Information on the age of onset of parentally reported eczema was collected by age 1 y using an interviewer-administered validated International Study on Asthma and Allergies in Childhood (ISAAC) questionnaire.
###end p 42
###begin title 43
Secondary outcome.
###end title 43
###begin p 44
###xml 33 41 <span type="species:ncbi:9606">children</span>
###xml 88 91 <span type="species:ncbi:9685">cat</span>
###xml 93 96 <span type="species:ncbi:9615">dog</span>
To assess allergic sensitisation children were skin prick tested at age 1 y (dust mite, cat, dog, grasses, milk, egg), and sensitisation was defined as a weal diameter 3 mm greater than the negative control.
###end p 44
###begin title 45
Environmental exposures.
###end title 45
###begin p 46
###xml 162 165 <span type="species:ncbi:9685">cat</span>
###xml 171 174 <span type="species:ncbi:9615">dog</span>
Pet exposure in early life was assessed by questionnaires administered during the home visit carried out within 4 wk after birth and defined as the presence of a cat or a dog in the house at birth.
###end p 46
###begin p 47
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 124 127 <span type="species:ncbi:9685">cat</span>
###xml 133 136 <span type="species:ncbi:9615">dog</span>
Allergen exposure was measured in dust samples collected at age 1 y by vacuuming 1 m2 of living-room floor for 2 min. Mite, cat, and dog allergen was quantitated using enzyme-linked immunoassays; results were expressed as allergen concentration (mug/g).
###end p 47
###begin title 48
FLG Genotyping
###end title 48
###begin p 49
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b001">1</xref>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b001">1</xref>
Genotyping for R501X was performed using a TAQMAN-based allelic discrimination assay (Applied Biosystems). Allelic discrimination was assessed using Applied Biosystems 7700 sequence detection system. Probes and primers were as described [1]. Mutation 2282del4 was genotyped by sizing of a fluorescent-labeled PCR fragment on an Applied Biosystems 3100 or 3730 DNA sequencer [1].
###end p 49
###begin title 50
Statistical Analysis
###end title 50
###begin p 51
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 0 8 <span type="species:ncbi:9606">Children</span>
###xml 80 88 <span type="species:ncbi:9606">children</span>
Children were classified according to a two level dominant genetic model (i.e., children were assigned as having a FLG mutation if they were heterozygous or homozygous for the null allele in at least one of the two SNPs).
###end p 51
###begin p 52
###xml 146 154 <span type="species:ncbi:9606">children</span>
Effects of environmental factors and their possible modification by genetic mutation were assessed by Kaplan-Meier curves and Cox regression. The children were retained in the analysis from birth until age at diagnosis of eczema, drop-out, or age 1 y, whichever came first. Simultaneous quantification of gene/environment effects was done by multiple Cox regression. Pet exposure at birth and pet allergen exposure were analysed separately. All analyses were carried out using SAS 9.1.3, SPSS 13.0, and the free-ware statistical package R (R Development Core Team, 2006). All estimates are reported with 95% confidence intervals [CI] in brackets.
###end p 52
###begin title 53
Results
###end title 53
###begin p 54
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 114 123 114 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050131-g001">Figures 1</xref>
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050131-g002">2</xref>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 490 493 490 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
The effects from FLG mutations in both cohorts occurred early in life as demonstrated by the Kaplan Meier curves (Figures 1 and 2), with hazard ratios (HR) of 2.90 (1.80-4.68) and 2.06 (1.40-3.05) in the first year and 0.71 (0.22-2.27) and 1.01 (0.48-2.51) after age 1 y (COPSAC and MAAS, respectively). We therefore focused the analysis on the interaction between FLG status and environmental exposures during the first year of life. Exposure variables in both cohorts were independent of FLG mutations.
###end p 54
###begin title 55
Kaplan-Meier Estimates of Cumulative Risk of Eczema in the COPSAC Cohort with and without FLG Mutation
###end title 55
###begin p 56
Numbers at risk at are given below the graph. Dashed line, no mutation; solid line, mutation.
###end p 56
###begin title 57
Kaplan-Meier Estimates of Cumulative Risk of Eczema in the MAAS Cohort with and without FLG Mutation
###end title 57
###begin p 58
Numbers at risk at are given below the graph. Dashed line, no mutation; solid line, mutation.
###end p 58
###begin title 59
COPSAC
###end title 59
###begin p 60
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b001">1</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b015">15</xref>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b001">1</xref>
###xml 7 14 <span type="species:ncbi:9606">infants</span>
###xml 185 193 <span type="species:ncbi:9606">children</span>
Of 411 infants, 379 of mixed European ancestry were genotyped for 501x and 2282del4 [1] as well as R2448X and S3247X [15]. The main mutated alleles 501x and 2282del4 were present in 40 children and exhibited a very strong association to the development of eczema as previously reported [1].
###end p 60
###begin p 61
###xml 33 41 <span type="species:ncbi:9606">children</span>
###xml 126 129 <span type="species:ncbi:9685">cat</span>
###xml 146 149 <span type="species:ncbi:9615">dog</span>
###xml 226 234 <span type="species:ncbi:9606">children</span>
###xml 249 257 <span type="species:ncbi:9606">children</span>
###xml 358 361 <span type="species:ncbi:9615">dog</span>
###xml 385 388 <span type="species:ncbi:9685">cat</span>
###xml 478 486 <span type="species:ncbi:9606">children</span>
###xml 506 509 <span type="species:ncbi:9685">cat</span>
###xml 514 517 <span type="species:ncbi:9615">dog</span>
###xml 549 552 <span type="species:ncbi:9685">cat</span>
###xml 583 586 <span type="species:ncbi:9615">dog</span>
###xml 616 619 <span type="species:ncbi:9685">cat</span>
###xml 624 627 <span type="species:ncbi:9615">dog</span>
###xml 697 705 <span type="species:ncbi:9606">children</span>
###xml 738 741 <span type="species:ncbi:9685">cat</span>
###xml 746 749 <span type="species:ncbi:9615">dog</span>
###xml 783 786 <span type="species:ncbi:9685">cat</span>
###xml 819 822 <span type="species:ncbi:9615">dog</span>
###xml 857 860 <span type="species:ncbi:9685">cat</span>
###xml 865 868 <span type="species:ncbi:9615">dog</span>
###xml 930 938 <span type="species:ncbi:9606">children</span>
Eczema was diagnosed in 28% (105 children) before age 1 y; 265 (75%) did not have pets in their home at birth, 38 (11%) had a cat, 37 (11%) had a dog, and 11 (3%) had both; information on pet ownership was not available in 28 children. Among the 38 children with main mutations and information on pet ownership, 26 (68%) did not have pets, seven (18%) had a dog only, four (11%) had a cat only, and one (3%) had both. Objective measure of allergen exposure was available in 339 children; 205 (60%) had low cat and dog allergen levels, 54 (16%) high cat allergen level, 54 (16%) high dog allergen level, 26 (8%) high cat and dog allergen levels, and 78 (23%) high mite allergen level. Among the 38 children with mutation, 22 (58%) had low cat and dog allergen levels, five (13%) high cat allergen level, nine (24%) high dog allergen level, two (5%) had high cat and dog allergen levels, and ten (26%) high mite allergen level. Six children were lost to follow-up during the first year but were included in the analyses for the available follow-up period.
###end p 61
###begin p 62
###xml 64 67 64 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 165 168 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 179 187 179 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050131-g003">Figure 3</xref>
###xml 251 254 251 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 340 343 340 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 480 481 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 534 535 534 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 591 594 591 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 711 712 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 804 805 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1070 1071 1070 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 124 127 <span type="species:ncbi:9685">cat</span>
###xml 263 266 <span type="species:ncbi:9685">cat</span>
###xml 277 280 <span type="species:ncbi:9615">dog</span>
###xml 355 358 <span type="species:ncbi:9685">cat</span>
###xml 369 372 <span type="species:ncbi:9615">dog</span>
###xml 451 454 <span type="species:ncbi:9685">cat</span>
###xml 520 523 <span type="species:ncbi:9615">dog</span>
###xml 578 581 <span type="species:ncbi:9685">cat</span>
###xml 776 779 <span type="species:ncbi:9685">cat</span>
###xml 865 868 <span type="species:ncbi:9615">dog</span>
###xml 938 946 <span type="species:ncbi:9606">children</span>
###xml 1008 1011 <span type="species:ncbi:9685">cat</span>
Kaplan-Meier plots suggested an increased risk of eczema due to FLG mutation, and a further increased risk of eczema due to cat exposure but only in the presence of FLG mutation (Figure 3). Backwards elimination in a multiple Cox regression including FLG status, cat exposure, dog exposure, mite allergen exposure, and interactions between FLG status and cat exposure, dog exposure, and mite allergen exposure showed a significant interaction between cat exposure and FLG status (p = 0.0008) and a significant effect of dog exposure (p = 0.05). An additional exploration of the cat exposure-FLG status interaction demonstrated an increased risk of developing eczema due to mutation (HR 2.26 [95% CI 1.27-4.00], p = 0.005), with an additional increased risk if also exposed to cat (HR 11.11 [3.79-32.60], p < 0.0001). The overall decrease in risk due to exposure to dog was quantified in an HR of 0.49 [0.24-1.01]. Analysis including only children carrying mutant alleles demonstrated a significant effect of cat ownership on development of eczema (HR 7.49 [2.37-23.67], p = 0.0006).
###end p 62
###begin title 63
###xml 117 120 <span type="species:ncbi:9685">Cat</span>
COPSAC: Kaplan-Meier Estimates of Cumulative Risk of Eczema during the First Year of Life Stratified on Mutation and Cat at Birth Status
###end title 63
###begin p 64
Numbers at risk at birth, 6, and 12 mo are given below the graph.
###end p 64
###begin p 65
###xml 16 19 <span type="species:ncbi:9685">cat</span>
###xml 42 45 <span type="species:ncbi:9685">cat</span>
Dashed line, no cat at birth; solid line, cat at birth.
###end p 65
###begin p 66
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 295 296 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 545 546 545 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 55 58 <span type="species:ncbi:9685">cat</span>
###xml 60 63 <span type="species:ncbi:9615">dog</span>
###xml 254 257 <span type="species:ncbi:9685">cat</span>
###xml 359 362 <span type="species:ncbi:9615">dog</span>
###xml 406 414 <span type="species:ncbi:9606">children</span>
###xml 476 479 <span type="species:ncbi:9685">cat</span>
For allergen exposure a similar analysis was made with cat, dog, and mite allergen levels. The model confirmed an increased risk of developing eczema due to mutation (HR 2.53 [1.45-4.41], p = 0.001) with an additional increase in risk if exposed to high cat allergen level (HR 3.77 [1.45-9.81], p = 0.006). In this analysis there was no significant effect of dog or mite allergens. Analysis including only children carrying mutant alleles demonstrated a significant effect of cat allergen exposure on development of eczema (HR 3.09 [1.17-8.19], p = 0.023).
###end p 66
###begin p 67
###xml 0 3 <span type="species:ncbi:9685">Cat</span>
###xml 57 60 <span type="species:ncbi:9685">cat</span>
###xml 133 136 <span type="species:ncbi:9615">dog</span>
###xml 190 193 <span type="species:ncbi:9615">dog</span>
Cat allergen exposure shows high agreement with reported cat exposure at 4 wk (simple Kappa coefficient 0.62 [0.51-0.73]). Similarly dog allergen exposure shows high agreement with reported dog exposure at 4 wk (simple Kappa coefficient 0.59 [0.48-0.70]).
###end p 67
###begin p 68
###xml 0 9 0 9 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 0 9 <span type="species:ncbi:1280">S. aureus</span>
S. aureus was identified from the perineum in one newborn before the age of 3 mo.
###end p 68
###begin title 69
MAAS
###end title 69
###begin p 70
###xml 7 15 <span type="species:ncbi:9606">children</span>
###xml 119 127 <span type="species:ncbi:9606">Children</span>
Of 940 children with questionnaire data on the age of onset of eczema, 513 provided a blood sample for DNA extraction. Children who provided DNA did not differ from those who did not in terms of family history, maternal age, socioeconomic status, history of eczema, allergic sensitisation, and pet ownership (data available on request).
###end p 70
###begin p 71
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 642 645 642 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 662 665 662 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 690 691 690 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 15 23 <span type="species:ncbi:9606">children</span>
###xml 259 267 <span type="species:ncbi:9606">children</span>
###xml 331 334 <span type="species:ncbi:9685">cat</span>
###xml 359 362 <span type="species:ncbi:9615">dog</span>
###xml 440 448 <span type="species:ncbi:9606">children</span>
###xml 520 523 <span type="species:ncbi:9685">cat</span>
###xml 554 557 <span type="species:ncbi:9615">dog</span>
###xml 598 601 <span type="species:ncbi:9685">cat</span>
###xml 606 609 <span type="species:ncbi:9615">dog</span>
###xml 701 704 <span type="species:ncbi:9685">Cat</span>
###xml 744 752 <span type="species:ncbi:9606">children</span>
###xml 780 783 <span type="species:ncbi:9615">dog</span>
A total of 503 children of mixed European ancestry had information on FLG main mutations (501x and 2282del4), pet ownership at birth, and the age of onset of eczema. By age 1 y, eczema was reported by 187/503 parents (37%). Mutated alleles were present in 50 children (10%); 324 (64%) did not own any pets at birth, 88 (18%) had a cat at home, 66 (13%) had a dog, and 25 (5%) had both. The frequency of pet ownership did not differ between children with or without FLG mutation (no pets 293/453 [64.7%] and 31/50 [62%], cat 77/453 [17%] and 11/50 [22%], dog 60/453 [13.2%] and 6/50 [12%], and both cat and dog 23/453 [5.1%] and 2/50 [4%], no FLG mutation versus FLG mutation, respectively, p = 0.84). Cat allergen exposure was available in 461 children, mite allergen in 458, and dog allergen in 460.
###end p 71
###begin p 72
###xml 153 156 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 183 191 183 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050131-g004">Figure 4</xref>
###xml 248 251 248 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 318 321 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 490 493 490 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 532 533 532 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 576 579 576 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 736 739 736 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 792 795 792 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 828 829 828 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 919 920 919 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 966 969 966 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 1012 1013 1012 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</italic>
###xml 1020 1021 1020 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1078 1079 1078 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1199 1202 1199 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 1213 1214 1213 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1379 1380 1379 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 97 100 <span type="species:ncbi:9685">cat</span>
###xml 105 108 <span type="species:ncbi:9615">dog</span>
###xml 127 135 <span type="species:ncbi:9606">children</span>
###xml 262 265 <span type="species:ncbi:9685">cat</span>
###xml 270 273 <span type="species:ncbi:9615">dog</span>
###xml 336 339 <span type="species:ncbi:9685">cat</span>
###xml 344 347 <span type="species:ncbi:9615">dog</span>
###xml 628 631 <span type="species:ncbi:9685">cat</span>
###xml 682 685 <span type="species:ncbi:9685">cat</span>
###xml 719 727 <span type="species:ncbi:9606">children</span>
###xml 765 768 <span type="species:ncbi:9685">cat</span>
###xml 862 865 <span type="species:ncbi:9615">dog</span>
###xml 984 987 <span type="species:ncbi:9615">dog</span>
###xml 1136 1140 <span type="species:ncbi:9685">cats</span>
###xml 1145 1149 <span type="species:ncbi:9615">dogs</span>
###xml 1248 1256 <span type="species:ncbi:9606">children</span>
###xml 1318 1321 <span type="species:ncbi:9685">cat</span>
Kaplan-Meier plots demonstrating the age of onset of eczema in the first year of life related to cat and dog ownership amongst children with and without FLG mutation are presented in Figure 4. The results of a multiple Cox regression that included FLG genotype, cat and dog ownership at birth, the interaction between FLG genotype with cat and dog ownership, and mite exposure and its interaction with FLG genotype indicated an increased risk of developing eczema in the first 12 mo due to FLG mutation (HR 1.95 [95% CI 1.13-3.36], p = 0.017). Furthermore, in the presence of FLG mutation, the risk increased further because of cat ownership at birth, with no significant effect of cat ownership being observed amongst children without FLG mutation (interaction of cat ownership at birth and FLG mutation, HR 3.82 [1.35-10.81], p = 0.011). There was a trend for dog ownership to increase the risk (HR 1.51 [0.96-2.37], p = 0.075), with no significant interaction of FLG genotype with dog ownership (HR 0.59 [0.16-2.20], p = 0.43) or mite allergen exposure (HR 1.15 [0.93-1.43], p = 0.21). There was no significant effect of having both cats and dogs (HR 1.57 [0.82-3.03]), or their interaction with FLG genotype (p = 0.96). Analysis including only children carrying mutant alleles demonstrated a significant effect of cat ownership on development of eczema (HR 2.47 [1.09-5.62], p = 0.03).
###end p 72
###begin title 73
###xml 115 118 <span type="species:ncbi:9685">Cat</span>
MAAS: Kaplan-Meier Estimates of Cumulative Risk of Eczema during the First Year of Life Stratified on Mutation and Cat at Birth Status
###end title 73
###begin p 74
Numbers at risk at birth, 6, and 12 mo are given below the graph.
###end p 74
###begin p 75
###xml 16 19 <span type="species:ncbi:9685">cat</span>
###xml 42 45 <span type="species:ncbi:9685">cat</span>
Dashed line, no cat at birth; solid line, cat at birth.
###end p 75
###begin p 76
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 399 402 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 490 493 490 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 541 542 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 637 638 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 715 718 715 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 746 747 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 81 84 <span type="species:ncbi:9685">cat</span>
###xml 90 93 <span type="species:ncbi:9615">dog</span>
###xml 163 166 <span type="species:ncbi:9685">cat</span>
###xml 168 171 <span type="species:ncbi:9615">dog</span>
###xml 382 385 <span type="species:ncbi:9685">cat</span>
###xml 476 484 <span type="species:ncbi:9606">children</span>
###xml 593 596 <span type="species:ncbi:9615">dog</span>
In terms of allergen exposure there was no significant correlation between mite, cat, and dog allergen levels. Multiple Cox regression that included FLG genotype, cat, dog, and mite allergen levels, and the interaction between genotype and allergen levels confirmed an increased risk of developing eczema due to mutation (HR 2.22 [1.27-3.89], p = 0.005) and the interaction between cat allergen and FLG genotype (with risk increasing risk with increasing allergen level among children with FLG mutation; HR for interaction 1.31 [1.03-1.67], p = 0.026). Nonsignificant trends were observed for dog allergen exposure (HR 1.07 [1.00-1.15], p = 0.06), the direction of which appeared to inverse in the interaction with FLG mutation (0.84 [0.68-1.05, p = 0.1]).
###end p 76
###begin title 77
Secondary outcomes.
###end title 77
###begin p 78
###xml 128 131 128 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 78 81 <span type="species:ncbi:9685">cat</span>
###xml 116 122 <span type="species:ncbi:9606">infant</span>
###xml 181 189 <span type="species:ncbi:9606">children</span>
###xml 231 234 <span type="species:ncbi:9685">cat</span>
###xml 249 252 <span type="species:ncbi:9615">dog</span>
Allergic sensitisation was uncommon in early life in both cohorts (in COPSAC, cat sensitisation was detected in one infant with FLG mutation at 6 mo but none at 18 mo; in MAAS, two children were skin test positive to mite, four to cat, and three to dog at age 1 y). We therefore did not analyse sensitisation further.
###end p 78
###begin title 79
Discussion
###end title 79
###begin title 80
Principal Findings
###end title 80
###begin p 81
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 350 353 350 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 115 118 <span type="species:ncbi:9685">cat</span>
###xml 234 237 <span type="species:ncbi:9685">cat</span>
###xml 246 249 <span type="species:ncbi:9615">dog</span>
###xml 336 344 <span type="species:ncbi:9606">children</span>
We have demonstrated a significant interaction between FLG loss-of-function main mutations (501x and 2282del4) and cat ownership at birth on the development of early-life eczema in two independent birth cohorts. Our data suggest that cat but not dog ownership substantially increases the risk of eczema within the first year of life in children with FLG loss-of-function variants, but not amongst those without. The observed effects were independent of allergic sensitisation.
###end p 81
###begin p 82
###xml 150 153 150 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 232 241 232 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050131-g001">Figures 1</xref>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050131-g002">2</xref>
For the primary outcome we selected age of onset of early eczema. The rationale for this is that in both cohorts the increased risk of eczema amongst FLG mutation carriers occurred only in the first year of life and not thereafter (Figures 1 and 2). Therefore development of eczema during the first year of life is the relevant outcome when studying this gene-environment interaction. This also means that the important environmental exposures that may interact with FLG in the development of eczema must occur in the first months of life. This limits the number of relevant exposures, as neonates typically live in a very sheltered environment.
###end p 82
###begin title 83
Limitations and Strengths
###end title 83
###begin p 84
###xml 773 782 773 782 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 773 782 <span type="species:ncbi:1280">S. aureus</span>
###xml 797 802 <span type="species:ncbi:9606">child</span>
This was a hypothesis-driven analysis. We hypothesized that weakening of physical barrier of skin in FLG deficient individuals may potentiate the effect of relevant environmental exposures. Therefore we investigated whether there is an interaction between FLG loss-of-function mutations with a range of environmental exposures for which the skin could be the relevant route of exposure. Since FLG is not expressed in either lungs or GI tract, we did not test exposures through such routes. We focused on the exposure that was associated with eczema in previous epidemiological studies and that was common for the two populations tested (domestic pets and indoor allergens). In addition, in COPSAC we explored the possibility of testing the effect of skin colonization with S. aureus, but only one child in the mutated group was colonized on the skin.
###end p 84
###begin p 85
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b009">9</xref>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b016">16</xref>
###xml 216 222 <span type="species:ncbi:9606">infant</span>
The different designs of the two cohorts prevented data pooling in favour of replication, and necessitated some differences in data analysis. Clinical outcomes were not identical, resulting in a higher prevalence of infant eczema in MAAS (parentally reported, 37%) compared to COPSAC (investigator-diagnosed, 28%). This suggests that MAAS was capturing milder cases and overreporting of eczema by parents. COPSAC provided closely monitored prospective data on eczema progression. The specificity of diagnosis was high, since the detailed phenotyping and management was carried out solely by the investigators, reducing the risk of misclassification [9], which is of particular importance in the clinical evaluation of eczema where interobserver variation is a problem [16]. Despite the differences in definition of primary outcome, we achieved replication.
###end p 85
###begin p 86
###xml 124 127 124 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 181 182 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 572 575 572 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 71 79 <span type="species:ncbi:9606">children</span>
###xml 99 102 <span type="species:ncbi:9685">cat</span>
###xml 589 592 <span type="species:ncbi:9685">cat</span>
###xml 676 679 <span type="species:ncbi:9685">cat</span>
We acknowledge the fact that the initial finding is based on only five children with eczema with a cat at home and carrying FLG mutation in COPSAC, but the power of the statistics (p < 0.0001) derives from the longitudinal dataset with the time of onset clearly distinguishing these populations. Cross-sectional analyses would not have such statistical power. Furthermore, it is worth noting that the findings were confirmed in the analysis of allergen levels, that pet ownership did not differ between those with and without the variant, and that the interaction between FLG variants and cat ownership was replicated in an independent cohort that included a larger number of cat exposed FLG mutation carriers.
###end p 86
###begin p 87
###xml 137 142 <span type="species:ncbi:9606">child</span>
Allergens levels were measured at age 1 y representing allergen exposure during the first year of life. Dust samples were taken from the child's mattress in COPSAC and from the lounge floor in MAAS, which resulted in different distribution of results (10-fold increase from third to fourth quartile in COPSAC with only 3-fold difference in MAAS, indicating that quartile analysis would not be appropriate in MAAS). Although we used different indices of allergen exposure, we obtained similar results.
###end p 87
###begin p 88
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b015">15</xref>
###xml 326 334 <span type="species:ncbi:9606">children</span>
In the original discovery in COPSAC of the loss-of-function variants 501x and 2282del4 in the gene encoding filaggrin, we demonstrated a strong association to the development of eczema in the first years of life. Two new SNPs within the filaggrin gene (R2447X and S3247X) have since been reported [15] and were found in eight children in COPSAC. However, these new SNPs are qualitatively different from the old mutations with some residual function as demonstrated by a significantly lower penetrance of eczema. Inclusion of the novel SNPs would therefore weaken our analyses by mixing a well-known strong risk factor with a weak risk factor, which furthermore is qualitatively different and therefore may have a different effect on the gene-environmental interactions studied. As a consequence we did not find it reasonable to formulate a dominant genetic model based on all four SNPs.
###end p 88
###begin title 89
Meaning of the Study
###end title 89
###begin p 90
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b017">17</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b018">18</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b019">19</xref>
Several studies have suggested an effect of early-life pet exposure on the development of atopic disease. However, the data are inconsistent, with some studies showing increased risk [17], and others decreased risk [18], or no effect [19]. These inconsistencies may be due in part to epidemiological artifacts. Recall bias is an obvious risk when exposure assessments are retrospective. Selection for keeping pets is another potential bias. The time from exposure to assessment of the health outcome has been long in some studies, which may lead to confounding by early modification of the exposure and therefore affect the long-term outcome. The causal-effect direction may be uncertain in retrospective assessments, as the pets may have been acquired after the disease onset. Furthermore, cross-sectional studies may report protective effects from pet exposure, when in fact individuals have removed the pet from the household because of the disease or the factors associated with a predisposition to disease. Importantly, in both our studies we documented pet exposure at birth (i.e., before eczema occurrence), thus eliminating uncertainty of the direction of association between exposure and disease. The findings were further supported by objective measures of allergen exposure.
###end p 90
###begin p 91
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b020">20</xref>
We only assessed animals living in the household, though other exposures outside the home may be relevant, but this would only have biased the risk estimates toward the null, potentially underestimating the true risk. Having pets has been reported to be biased from socioeconomic status, smoking habits, and parental allergic rhinitis [20], but it is unlikely to affect the genetic distribution in the study population and could therefore not act as confounder.
###end p 91
###begin p 92
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 407 408 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b002">2</xref>
###xml 680 681 680 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050131-b008">8</xref>
###xml 23 26 <span type="species:ncbi:9685">cat</span>
###xml 127 130 <span type="species:ncbi:9685">cat</span>
###xml 411 414 <span type="species:ncbi:9685">Cat</span>
###xml 708 711 <span type="species:ncbi:9685">cat</span>
###xml 810 813 <span type="species:ncbi:9685">cat</span>
The mechanism by which cat exposure drives the development of eczema is unknown. Our data suggest that it does not act through cat-specific immunoglobulin E (IgE). This is in keeping with previous studies showing that the effect of FLG loss-of-function mutations was equally strong on allergic and nonallergic eczema, demonstrating that the development of eczema is not dependent on allergic sensitisation [2]. Cat exposure may act through other nonallergic mechanisms such as endotoxins. COPSAC recently reported that bacterial colonization of the airways in neonates was associated with later development of recurrent wheeze, asthma, and increased total immunoglobulin E (IgE) [8]. It may be possible that cat exposure mediates its effect in the FLG mutated genotypes via altered bacterial exposure, or that cat exposure may be a surrogate marker for other unknown environmental influences penetrating the imperfect skin barrier because of defective profilaggrin synthesis.
###end p 92
###begin title 93
Conclusions
###end title 93
###begin p 94
###xml 280 283 280 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLG</italic>
###xml 211 214 <span type="species:ncbi:9685">cat</span>
###xml 267 274 <span type="species:ncbi:9606">infants</span>
Although there are many new susceptibility genes for complex disorders following genome-wide association studies, there are very few gene-environment studies. Our findings of a consistent effect from early-life cat ownership on the phenotypic expression of eczema in infants with FLG loss-of-function mutations in two independent birth cohorts is an example of gene-environment interaction in a common complex disease, demonstrating that such gene-environment interactions exist and are detectable given appropriately detailed studies of environmental exposures.
###end p 94
###begin title 95
Supporting Information
###end title 95
###begin title 96
Spanish Translation of the Abstract by Antonio Nieto
###end title 96
###begin p 97
(21 KB DOC)
###end p 97
###begin p 98
Click here for additional data file.
###end p 98
###begin title 99
French Translation of the Abstract by Florent Baty
###end title 99
###begin p 100
(29 KB DOC)
###end p 100
###begin p 101
Click here for additional data file.
###end p 101
###begin title 102
German Translation of the Abstract by Anna Molter
###end title 102
###begin p 103
(25 KB DOC)
###end p 103
###begin p 104
Click here for additional data file.
###end p 104
###begin p 105
###xml 30 38 <span type="species:ncbi:9606">children</span>
###xml 161 169 <span type="species:ncbi:9606">children</span>
The authors wish to thank the children and parents participating in the COPSAC cohort as well as the COPSAC study team. The authors would like to thank the MAAS children and their parents for their continued support and enthusiasm. We acknowledge the dedication of MAAS study team; we thank Julie Morris (MSc) for statistical advice.
###end p 105
###begin title 106
Abbreviations
###end title 106
###begin p 107
confidence interval
###end p 107
###begin p 108
Copenhagen Study on Asthma in Childhood
###end p 108
###begin p 109
filaggrin
###end p 109
###begin p 110
hazard ratio
###end p 110
###begin p 111
Manchester Asthma and Allergy Study
###end p 111
###begin title 112
References
###end title 112
###begin article-title 113
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis
###end article-title 113
###begin article-title 114
Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march
###end article-title 114
###begin article-title 115
Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations
###end article-title 115
###begin article-title 116
Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis
###end article-title 116
###begin article-title 117
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
###end article-title 117
###begin article-title 118
The Copenhagen Prospective Study on Asthma in Childhood (COPSAC): design, rationale, and baseline data from a longitudinal birth cohort study
###end article-title 118
###begin article-title 119
###xml 40 47 <span type="species:ncbi:9606">infants</span>
Intermittent inhaled corticosteroids in infants with episodic wheezing
###end article-title 119
###begin article-title 120
Childhood asthma after bacterial colonization of the airway in neonates
###end article-title 120
###begin article-title 121
###xml 149 157 <span type="species:ncbi:9606">children</span>
Development of atopic dermatitis during the first 3 years of life: the Copenhagen prospective study on asthma in childhood cohort study in high-risk children
###end article-title 121
###begin article-title 122
Diagnostic features of atopic dermatitis
###end article-title 122
###begin article-title 123
Specific IgE antibodies in the diagnosis of atopic disease. Clinical evaluation of a new in vitro test system, UniCAP, in six European allergy clinics
###end article-title 123
###begin article-title 124
Current asthma and respiratory symptoms among pupils in relation to dietary factors and allergens in the school environment
###end article-title 124
###begin article-title 125
The National Asthma Campaign Manchester Asthma and Allergy Study
###end article-title 125
###begin article-title 126
Manchester cohort
###end article-title 126
###begin article-title 127
Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema
###end article-title 127
###begin article-title 128
The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis
###end article-title 128
###begin article-title 129
Indoor allergen exposure is a risk factor for sensitization during the first three years of life
###end article-title 129
###begin article-title 130
###xml 12 16 <span type="species:ncbi:9615">dogs</span>
###xml 21 25 <span type="species:ncbi:9685">cats</span>
Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age
###end article-title 130
###begin article-title 131
###xml 38 41 <span type="species:ncbi:9685">cat</span>
Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre Allergy Study Group
###end article-title 131
###begin article-title 132
Heredity, pet ownership, and confounding control in a population-based birth cohort
###end article-title 132
###begin p 133
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 523 531 <span type="species:ncbi:9606">patients</span>
Author contributions. HB, CNAP, and AC conceived and designed the study and obtained funding. KB and LBH collected and assembled the data. HB and AC analysed and interpreted the data. CBP provided statistical expertise. HB drafted the article. AS, CNAP, KB, IM, SM, CBP, LBH, BL, JH, AW, and AC contributed to the critical revision of the article for important intellectual content. HB, AS, CNAP, KB, IM, SM, CBP, LBH, BL, JH, AW, and AC contributed to the final approval of the article and provision of study materials or patients.
###end p 133
###begin p 134
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: Copenhagen Study on Asthma in Childhood (COPSAC) is funded by research funds. The main funds are: the Lundbeck Foundation; the Pharmacy Foundation of 1991; Augustinus Foundation; and the Danish Medical Research Council. Manchester Asthma and Allergy Study (MAAS) is funded by the Moulton Charitable Trust and Asthma UK. AS is supported by the Collins' Charitable Trust. The funders did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 134
###begin p 135
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: HB has been a consultant to, paid lecturer for, and holds sponsored grants from AstraZeneca, GSK, Merck, MedImmune, NeoLab, and Pfizer. He does not hold stock or options in any pharmaceutical company in the respiratory field. IM has filed two patents relating to genetic testing and therapy development aimed at the filaggrin gene. AC receives grant and research support from GlaxoSmithKline and is a consultant for GlaxoSmithKline and UCB Pharma, ALK; and at the speaker's bureau of Astra-Zeneca, GlaxoSmithKline, and UCB Pharma, ALK.
###end p 135

